We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+16.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$365M
AUM Growth
+$364M
Cap. Flow
+$21.3M
Cap. Flow %
5.84%
Top 10 Hldgs %
39.32%
Holding
152
New
4
Increased
27
Reduced
26
Closed
24

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.65M
2
META icon
Meta Platforms (Facebook)
META
+$8.13M
3
ORCL icon
Oracle
ORCL
+$6.47M
4
BLK icon
Blackrock
BLK
+$6.1M
5
NVO
Novo Nordisk
NVO
+$5.43M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$7.49M
2
CB icon
Chubb
CB
+$6.73M
3
F icon
Ford
F
+$2M
4
ASML icon
ASML
ASML
+$199K
5
COST icon
Costco
COST
+$182K

Sector Composition

Rank Sector Weight
1 Technology 29.23%
2 Healthcare 19.04%
3 Financials 12.04%
4 Communication Services 9.56%
5 Consumer Discretionary 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$213B
$6.96M 1.91%
13,758
+20
+0.1% +$10.7K
ORCL icon
27
Oracle
ORCL
$374B
$6.75M 1.85%
63,709
+55,905
+716% +$6.47M
APD icon
28
Air Products & Chemicals
APD
$65.7B
$6.73M 1.85%
23,756
+222
+0.9% +$65.1K
ULTA icon
29
Ulta Beauty
ULTA
$22B
$6.34M 1.74%
15,877
-19
-0.1% -$8.31K
DE icon
30
Deere & Co
DE
$160B
$6.19M 1.7%
16,394
+218
+1% +$89.9K
FISV
31
Fiserv Inc
FISV
$28.8B
$6M 1.65%
53,136
+665
+1% +$81.9K
MS icon
32
Morgan Stanley
MS
$331B
$5.86M 1.61%
71,809
+604
+0.8% +$52.4K
BLK icon
33
Blackrock
BLK
$169B
$5.64M 1.55%
+8,726
New +$6.1M
NVO
34
Novo Nordisk
NVO
$208B
$5.6M 1.54%
+61,612
New +$5.43M
PEP icon
35
PepsiCo
PEP
$190B
$5.24M 1.44%
30,900
-37
-0.1% -$6.72K
SBUX icon
36
Starbucks
SBUX
$120B
$5.22M 1.43%
57,187
-111
-0.2% -$10.9K
BX icon
37
Blackstone
BX
$102B
$3.72M 1.02%
34,737
– –
SYK icon
38
Stryker
SYK
$125B
$3.04M 0.83%
11,114
+75
+0.7% +$21.5K
ZBH icon
39
Zimmer Biomet
ZBH
$18.2B
$2.69M 0.74%
23,984
-36
-0.1% -$4.57K
GOOG icon
40
Alphabet (Google) Class C
GOOG
$4.36T
$2.02M 0.55%
15,340
– –
REGN icon
41
Regeneron Pharmaceuticals
REGN
$78.5B
$1.9M 0.52%
2,308
– –
CVS icon
42
CVS Health
CVS
$133B
$1.81M 0.5%
25,867
-279
-1% -$19.8K
QCOM icon
43
Qualcomm
QCOM
$155B
$1.42M 0.39%
12,803
-25
-0.2% -$2.9K
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.34M 0.37%
3,829
-20
-0.5% -$7.09K
ADBE icon
45
Adobe
ADBE
$99.5B
$1.18M 0.32%
23,098
+210
+0.9% +$110K
J icon
46
Jacobs Solutions
J
$15.9B
$1.08M 0.3%
9,564
+1
+0% +$108
WMT icon
47
Walmart Inc
WMT
$885B
$914K 0.25%
17,160
– –
MCD icon
48
McDonald's
MCD
$192B
$861K 0.24%
3,269
– –
F icon
49
Ford
F
$58.5B
$848K 0.23%
68,309
-153,762
-69% -$2M
SSNC icon
50
SS&C Technologies
SSNC
$18.1B
$702K 0.19%
13,372
– –
1
2
3 4 5

Similar funds

FGN
Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return
SFAM
Springhill Fund Asset Management Hong Kong $20.9M AUM
NTIMCH
New Thinking Investment Management Company (HK) Hong Kong $20.4M AUM 4.24% 1-Year Est. Return
GDCML
Galaxy Digital Capital Management LP New York $13.5M AUM
AA
AlphaQ Advisors Winter Park, Florida $41.7M AUM 12.96% 1-Year Est. Return
GIS
Grayhawk Investment Strategies Calgary, Alberta, Canada $43.9M AUM 6.23% 1-Year Est. Return
TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OWP
Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return

Cyrus J. Lawrence's Q3 2023 Portfolio in Review

As of Q3 2023, Cyrus J. Lawrence held 152 positions worth $365M, up 78,774% from $462K the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Cyrus J. Lawrence deployed $21.3M of net new capital in Q3 2023, opening 4 new positions and adding to 27 existing holdings. Its largest new stake was Merck: 89,544 shares worth $9.22M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $7.49M trimmed.

  • Cyrus J. Lawrence's largest Q3 2023 buy was Merck: 89,544 shares worth $9.22M.
  • Cyrus J. Lawrence added most to Meta Platforms (Facebook) in Q3 2023, an estimated $8.13M increase.
  • Cyrus J. Lawrence's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $7.49M.
  • Cyrus J. Lawrence fully exited RTX Corp in Q3 2023, selling an estimated $5.76K.
  • Cyrus J. Lawrence's ten largest holdings make up 39% of its $365M portfolio in Q3 2023.
  • Cyrus J. Lawrence opened 4 new positions and closed 24 in Q3 2023.
  • Cyrus J. Lawrence's portfolio value rose 78,774% quarter-over-quarter to $365M.

Based on Cyrus J. Lawrence's 13F filing for Q3 2023, filed 9 Nov 2023.